Cleared Traditional

K860713 - LACTATE DEHYDROGENASE (LD) FOR CONT. FL...

K860713 is the FDA 510(k) clearance for LACTATE DEHYDROGENASE (LD) FOR CONT. FL... by Catachem, Inc.. It is a Class 2 Chemistry device (product code CFJ) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K860713 · Catachem, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1986
Decision
57d
Days
Class 2
Risk

K860713 is an FDA 510(k) clearance for the LACTATE DEHYDROGENASE (LD) FOR CONT. FLOW INSTRUM.. Classified as Nad Reduction/nadh Oxidation, Lactate Dehydrogenase (product code CFJ), Class II - Special Controls.

Submitted by Catachem, Inc. (Port Chester, US). The FDA issued a Cleared decision on April 24, 1986 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1440 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Catachem, Inc. devices

Submission Details

510(k) Number K860713 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 1986
Decision Date April 24, 1986
Days to Decision 57 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 88d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase

All 83
Devices cleared under the same product code (CFJ) and FDA review panel - the closest regulatory comparables to K860713.
LDP REAGENT CARTRIDGE (NO. 88216)
K862027 · Hi Chem, Inc. · Jun 1986
LACTATE DEHYDROGENASE (LD) PROCEDURE
K861662 · Data Medical Associates, Inc. · May 1986
HI CHEM DIAGNOSTICS LDL REAGENT CARTRIDGE
K861419 · Hi Chem, Inc. · Apr 1986
L D H-L (LACTIC DEHYDROGENASE) REAGENT
K860728 · Trace Scientific , Ltd. · Apr 1986
LDH-P (LACTIC DEHYDROGENASE) REAGENT
K860729 · Trace Scientific , Ltd. · Apr 1986
LDH (OPTIMIZED) REAGENT
K860029 · Sigma Chemical Co. · Feb 1986